Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Last patient included in Sedana Medical's pivotal IsoConDa study

Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced that the last patient has now been included in the pivotal IsoConDa study. Thus, all 300 patients have been included and the study is expected to show top-line results during Q2 2020.“This is a true milestone for Sedana Medical. It is extremely gratifying that we keep the schedule in the world's largest study of inhaled sedation in intensive care. We expect to be able to present top-line results in the second quarter of 2020 and thus be able to submit our application for European market approval in 16 European countries in a

Africa Energy to Present at Investor Meeting in Stockholm

January 13, 2020 – Africa Energy Corp. (TSX Venture: AFE) (Nasdaq First North: AEC) (“Africa Energy” or the “Company”), an oil and gas company with exploration assets offshore South Africa and Namibia, announces that the Company’s President and Chief Executive Officer, Garrett Soden, will be presenting to shareholders and investors at a town hall meeting in Stockholm, Sweden on Monday, January 20, 2020, at 18:30 Central European Time (CET). The town hall meeting will be held at Näringslivets Hus on Storgatan 19 in Stockholm (local Industrisalen). Shareholders and investors are requested

Scandion Oncology to attend the JP Morgan 38th Annual Healthcare Conference

Scandion Oncology A/S (“Scandion Oncology”) Chief Executive Officer Nils Brünner and Chairman of the Board Peter Høngaard will be attending the JP Morgan 38th Annual Healthcare Conference 13-16 January 2020 in San Francisco.From January 13 to 16, 2020, Scandion Oncology will participate at the J.P. Morgan Healthcare Conference in San Francisco, USA. This annual conference, with more than 9,000 representatives from the pharmaceutical industry, the financial and service sectors and from academic institutions, is the largest of its kind in the world. CEO Nils Brünner says: According to our

Hansa Biopharma provides business update ahead of the JP Morgan Global Healthcare Conference

•    Responses to Day 120 questions submitted for EMA MAA of imlifidase•    First patients dosed in GBS trial; Enrollment in anti-GBM trial near completion•    Solid year-end cash positionLund, Sweden January 12, 2020. Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced a business update for the fourth quarter 2019 and preliminary, unaudited key financials for its financial year 2019.  The company will be participating in the JP Morgan Global Healthcare Conference  in San Francisco from January 13 to 16, 2020. 2019

SBB controls approximately 91.2 percent of the shares in Hemfosa

Read more at www.sbb-hemfosa.se. For further information, please contact: Ilija Batljan, CEO and Founder of Samhällsbyggnadsbolaget i Norden AB, +46 70 518 39 67, ilija@sbbnorden.se This information is information that Samhällsbyggnadsbolaget i Norden AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above on January 10, 2020, at 21:30 CET. About Samhällsbyggnadsbolaget i Norden AB (publ) The company’s strategy is to own, manage and develop community

CURRENCY EXCHANGE RATES FOR THE FOURTH QUARTER 2019

Currency exchange rates for significant currencies in Betsson AB’s financial reports are found below. The exchange rates have no material impact on the Group’s operations, but affects the reported results when translated into the reporting currency SEK. Income statement average rates to SEK   January- December 2019  January-December 2018 YoY DeltaEUR 10.589 10.257 3.2%GBP 12.066 11.593 4.1%GEL 3.354 3.432 -2.3%NOK 1.075

QuickCool AB (publ): European High Growth Opportunities Securitization Fund requests conversion of convertible bonds

European High Growth Opportunities Securitization Fund has by notice to the board of directors of QuickCool AB (Publ) ("QuickCool") called upon its right to conversion of convertible bonds previously issued in accordance with the financing solution announced by QuickCool through a press release on 21 June 2018.QuickCool has received notification from European High Growth Opportunities Securitization Fund regarding conversion of convertible bonds into 500 000 shares in QuickCool, corresponding to SEK 500 000 of the convertible loan. The conversion price per share is SEK 1,00. Upon

UK Competition Appeal Tribunal issues judgement regarding Tobii’s Divestiture of Smartbox

Tobii AB (publ) today comments on the latest events regarding the Smartbox acquisition. The UK Competition Appeal Tribunal (CAT) today issued a judgement regarding Tobii’s appeal concerning the divestiture of Smartbox. In parallel to the appeals process, Tobii has maintained an ongoing divestiture process in line with the British Competition and Market Authority’s (CMA) initial decision. CAT has today issued a judgement finding that the CMA was only partially correct in its decision making. CAT has asked Tobii and CMA for further submissions and is expected to issue a final order within

Correction: NoHo Partners Plc: Managers' transactions (Niemi)

NoHo Partners Plc MANAGERS' TRANSACTIONS 10 January 2020 at 18:15 Correction: NoHo Partners Plc: Managers' transactions (Niemi)Correction to NoHo Partners Plc's Managers' Transactions notification published on 10 January 2020 at 2:30 p.m. Due to a technical error, the number and price of shares in transaction details and in aggregated transactions were misreported. Below is the corrected notification. Person subject to the notification requirementName: NIEMI, HANNA-STIINAPosition: Closely associated person Person discharging

DNB ASA - Share buy-back status after week 2

During week 2 2020, DNB ASA has purchased 755 000 own shares at an average price of NOK 165.31 per share. After this, DNB ASA owns a total of 10 688 000 own shares. The repurchase of shares is part of the share buy-back programme announced by DNB ASA on 24 October 2019, as subsequently amended by an announcement on 20 November and 12 December 2019. The share buy-back programme comprises up to approximately 23.7 million shares, of which up to approximately 15.6 million shares may be repurchased in the open market. The rest will be redeemed from the state of Norway on a proportionate basis,

#20-11 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

#20-10 Delisting of certain derivatives from NGM

Certain derivatives will be delisted from NGM.For more details see attached files. For further information concerning this NGM notice please contact: Listing department on +46 8 566 390 20 or at listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

Sandvik distributes proforma numbers for Sandvik Mining and Rock Technology

Sandvik announced on 28 October 2019 that the agreement to divest the majority of Drilling and Completions (Varel) was signed. As earlier stated, the related write-down impacted the net profit in the fourth quarter of 2019 by -3.9 billion SEK, out of which -4.2 billion SEK impacted operating profit negatively whilst impact on taxes was positive by +0.3 billion SEK. Related to the ongoing divestment, Varel has been moved out of Sandvik Mining and Rock Technology and is instead reported in Other Operations until expected closure of the deal, during the first quarter of 2020. In line

Multiconsult ASA – share repurchase programme

Reference is made to the stock market announcement on 4 December 2019, where Multiconsult ASA announced completion of share buyback, share loan agreement, and employee share purchase programme. With reference to the share loan agreement with its largest shareholder Stiftelsen Multiconsult, Multiconsult ASA will deliver the full amount of shares back to Stiftelsen Multiconsult.Today, Multiconsult ASA initiates a share repurchase programme of up to 100 000 of its own shares for the purpose of delivering the shares back to Stiftelsen Multiconsult. The programme will begin 10 January 2020 and

Cereno Scientific Announces Presentation at Biotech Showcase™ 2020

Mölndal, Sweden - Cereno Scientific, a company developing preventive therapies to restore the body’s own defense system against blood clots to treat cardiovascular and rare diseases, announced today that Cereno’s Chief Executive Officer, Sten R. Sörensen, will present at Biotech Showcase™ 2020 being held January 13–15, 2020 at the Hilton San Francisco Union Square.The details of Cereno’s presentation are as follows: Date: Tuesday, January 14, 2020 Time: 9:30 AM Room: Yosemite C (Ballroom Level) Venue: Hilton San Francisco Union Square Hotel, 333 O’Farrell Street, San

OptiFreeze has finished the OptiDry tests in Germany with good results.

OptiFreeze has, as has previously been informed, been running industrial trials with one of Europe’s largest companies regarding drying of vegetables and herbs. The result of the trials has been very positive.The next step in this process will be to extend the trials into more product areas, which will take place in February/March 2020. Following this, the parties will evaluate the results. OptiFreeze has decided not to publish the name of the customer because of commercial and strategic reasons at the customer. We have co-operated with this customer for some time and together we have

Consultics and Inzyon announces distribution partnership

Consultics Ltd and Inzyon AB today announce that they have entered into a business partnership for the distribution of Inzyon’s Enterprise Insight Solutions.Insights Management is a fast-growing segment with application areas in most industries and the two companies see significant value in combining their concepts and market reach.                                 “It is with great pleasure that we welcome Inzyon to the partnership portfolio of Consultics. At Consultics we constantly look to improve our partnerships by adding more dynamic tools and technologies for Insights Management

Flowscape signs European sales agreement with Ricoh

Flowscape has signed a reseller agreement with Ricoh Europe. The agreement includes Flowscape’s Smart office solution and C-One, allowing Ricoh to offer Flowscape to its customers consistently across 22 European countries. Flowscape has already delivered together with Ricoh in Sweden, United Kingdom and Switzerland“That we now are included in every Ricoh seller's product portfolio is an important step in our strategy to sell and deliver with global partners. Ricoh Europe is a leading player for office-based digital solutions with hundred thousand of existing customers in Europe. So far,

Operating officer utilizes option and buys 30,000 shares

Gert Gustafsson, Operating officer for 7 of a total of 23 business units within Vitec, has acquired 30,000 shares of Series B. 2020-01-10. The acquisition is made through the exercise of options issued by the founders Lars Stenlund and Olov Sandberg in January 2017.For more information, please contact Patrik Fransson, Investor Relations patrik.fransson@vitec.se +46-76-9428597      About Vitec Vitec is market leader for Vertical Market Software in the Nordic region. We develop and deliver standard niche software. Vitec grows through acquisitions of well-managed and well-

Grants from Gasum Gas Fund for 2020 are open for applications

The energy company Gasum provides grants to researchers every year. Research, technology and innovations play key roles in the journey towards a clean and sustainable Nordic gas ecosystem. A forerunner in the gas and energy sector, Gasum invests in the development of new technologies, concepts and energy systems. The application period for the year’s grants are open and will end in February 7, 2020.The Gasum Gas Fund aims to respond to society’s transformational challenges by developing energy solutions based on gas and producing information supporting the development of the gas sector.

Metsä Tissue is investing in a new production line at the Raubach mill

Metsä Tissue press release 10 January 2020Metsä Tissue, a part of Metsä Group, is investing in a new production line for professional tissue papers at its Raubach mill in Germany. The total value of the investment is approximately EUR 10 million. The new MF4 production line with annual production capacity of 16,000 tonnes will produce folded hand towels, which are used typically in public washrooms. “Demand for professional tissue paper products is growing and according to our strategy, we are increasing our capacity to meet the market situation. The investment will strengthen our

Result of bondholders’ meetings

Reference is made to the previous announcements on December 13, 2019 regarding summons to bondholders’ meetings in ODF08 (ISIN NO0010782584) and ODF09 (ISIN NO0010796238) on January 10, 2020.  The meetings were held today and the proposed resolutions were approved by a qualified majority in each of the bondholders’ meetings. Please see the attached confirmation to this effect from Nordic Trustee.  For questions, please contact: Terje Iversen, CFO, Odfjell SE Tel: +47 932 40 359 Email: terje.iversen@odfjell.com Gustav Sannem, VP Finance, Odfjell SETel: +47 452 69 641

Share options granted

Observe Medical ASA Board of Directors has on January 9 2020, as part of a long-term incentive plan, approved granting Björn Larsson (CEO in Observe Medical ASA) 60 000 series A options and 60 000 series B options. Each option, when exercised, will give the right to acquire one share in Observe Medical ASA. The options are granted without consideration.  The series A options are granted vest over a 3 year period, with 1/3 after 12 months, 1/3 after 24 months and the last third after 36 months. The series A option shares have a 12 month lock-up period tied to them. Options that have not

Fortum concludes the sale of its district heating business in Joensuu, Finland

FORTUM CORPORATION STOCK EXCHANGE RELEASE 10 JANUARY 2020 AT 14:35 EETRelease category: Other information disclosed according to the rules of the Exchange Fortum has today concluded the sale of its district heating business in Joensuu, Finland to Savon Voima Oyj, as announced on 20 December 2019. The total consideration of the sale on a debt- and cash-free basis is approximately EUR 530 million. Fortum will record a tax exempt capital gain of approximately EUR 430 million in the City Solutions segment’s first-quarter 2020 results. Fortum Corporation Ingela Ulfves, VP, IR and

There are no items matching the current filter
There are no more items matching the current filter
Back to top